SARS‑CoV‑2 Diagnostic Panel in UAE | 490 AED | DHA Licensed Laboratory

Executive Summary & Core Metrics

Comprehensive Diagnostic Assessment for COVID‑19 Status

This integrated panel combines molecular, serological, and hematological assays to deliver a complete clinical picture of SARS‑CoV‑2 infection, immune response, and systemic involvement.

Diagnostic Sensitivity: 99.9% via ISO‑accredited multimodal processing (RT‑qPCR + serology + hematology).
Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily 8 AM–11 PM; direct billing verification via WhatsApp +971 54 548 8731.
Clinical Guidance: Telephonic post‑test interpretation and management advice provided by the referring clinician.
Price: 490 AED inclusive of all laboratory procedures and courier services.

Test Overview & Methodology

The SARS‑CoV‑2 Diagnostic Panel employs three complementary analytical platforms to evaluate active viral shedding, humoral immune response, and haematological markers of inflammation. Real‑time reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) detects viral RNA with high analytical sensitivity. Immunoturbidimetry quantifies IgM and IgG antibodies against SARS‑CoV‑2 spike and nucleocapsid antigens. Electrical impedance and volume‑conductivity‑scatter (VCS) technology performs a complete blood count with five‑part leukocyte differential to identify lymphopenia, neutrophilia, or other inflammatory signatures.

Feature	SARS‑CoV‑2 Diagnostic Panel	Standalone RT‑PCR Only
Precision	Multimodal RT‑qPCR + serology + hematology; 99.9% sensitivity	Single‑target RNA detection only
Methodology	Real‑Time RT‑qPCR (viral RNA), Immunoturbidimetry (IgM/IgG), Electrical Impedance/VCS (CBC+5‑part diff)	RT‑PCR (single gene target)
Turnaround Time	2 days	6–24 hours
Clinical Context	Infection, immune response, and systemic inflammation picture	Viral presence only

Physician Insight & Safety Protocols

“As a general practitioner managing patients across the spectrum of COVID‑19 presentations, I recognise the diagnostic limitations of a single PCR result. This panel provides layered information: viral load trajectory, antibody conversion timing, and haematological markers that guide clinical decision‑making. I advise every patient to correlate their laboratory findings with symptom chronology and exposure history. Our tele‑support team ensures that each result is contextualised and that appropriate isolation or treatment steps are clearly communicated.”

— Dr. Ajay Singh, General Practitioner | DHA Registration ID: 36234132

⚠ Medication Advisory

Do not alter, pause, or discontinue any prescribed antiviral, anti‑inflammatory, or immunomodulatory medication without direct consultation with your treating physician. Laboratory results should complement—not replace—clinical judgement and ongoing therapeutic regimens.

Patient Safety Exclusion Criteria & Emergency Red Flags

Exclusion Criteria: Inability to tolerate nasopharyngeal or oropharyngeal swabbing; active epistaxis or bleeding diathesis that contraindicates venipuncture; known hypersensitivity to transport medium or swab materials.
Emergency Red Flags (seek immediate emergency care): Sudden onset of severe dyspnoea, persistent chest pain or pressure, new‑onset confusion, cyanosis of the lips or face, or fever exceeding 39 °C that does not respond to antipyretics.

Patient FAQ & Clinical Guidance

1. What does a positive PCR result in this panel mean?

A positive RT‑qPCR result indicates active shedding of SARS‑CoV‑2 RNA and current viral replication. You must initiate home isolation in accordance with UAE Health Authority guidelines and inform all close contacts of potential exposure. Our clinical team will contact you to review the result and coordinate any required follow‑up testing or referral.

2. What preparation is needed for the home collection appointment?

Overnight fasting is preferred for the blood draw; you may consume plain water. The phlebotomist will collect a nasopharyngeal swab, blood serum, and whole blood sample. Please have your Emirates ID and the completed Clinical Information Form ready for verification. The entire process takes approximately 15–20 minutes.

3. When will I receive my results and how should I interpret the serology findings?

Results are available within 2 days of sample collection. A positive IgM with negative PCR suggests recent or early‑phase infection; concurrent positive IgG with negative PCR indicates past infection and convalescent immunity. Our clinical team will provide a detailed telephone explanation of your serological and haematological profile to ensure accurate interpretation.

UAE Regulatory & Data Privacy Adherence

This laboratory service operates in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical testing and patient consent procedures adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability. The laboratory is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139) and follows DHA/MOHAP guidelines for infectious disease diagnostic panels. Sample collection, transport, and processing are conducted under strict temperature‑controlled cold‑chain conditions to maintain specimen integrity and data confidentiality.

Clinical & Logistical Metadata

Test Name	SARS‑CoV‑2 Diagnostic Panel (RT‑qPCR + Serology + Hematology)
Price (AED)	490
Turnaround Time	2 Days
Sample Type / Matrix	Nasopharyngeal/Oropharyngeal Swab, Blood Serum, Whole Blood
Methodology Used	Real‑Time RT‑qPCR, Immunoturbidimetry, Electrical Impedance/VCS
ICD-10-CM Code	U07.1
LOINC Code	94531-1
DHA Facility License & Laboratory Address	DHA Facility License Number: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE